SCHEMBL7653091

SCHEMBL7653091

CN(CCC1CCN(Cc2ccccc2)CC1)C(=O)c1ccccc1S(=O)(=O)Cc1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4501690 0.85 ACHE (0.77) ACHE
SCHEMBL12043773 0.81 ACHE (1.00) ACHE
SCHEMBL14601870 0.81 ACHE (0.71) ACHE
SCHEMBL7808064 0.78 ACHE (0.75) ACHE
SCHEMBL14601862 0.77 ACHE (0.77) ACHE
SCHEMBL14601871 0.75 ACHE (0.78) ACHE
SCHEMBL14601874 0.75 ACHE (0.81) ACHE
SCHEMBL9062199 0.74 ACHE (0.59) ACHE
SCHEMBL8782440 0.73 ACHE (0.71) ACHE
Hydrochloric Acid SCHEMBL9375464 0.72 ACHE (0.68) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002072025-A2 IMPROVING POSTSYNAPTIC RESPONSE BY A COMBINATION OF 4-MINOPYRIDINE AND AGONIST THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES (US) 2002-09-19 WO disclosed